The Martin Luther King Center, in collaboration with the UK Office for Institutional Diversity and the Office of Student and Academic Life, will host the fourth annual UK Men of Color Symposium.
On this episode of "Behind the Blue," Matt Southward, an assistant professor in the Department of Psychology in the College of Arts and Sciences, discusses the signs and symptoms of winter blues.
A new student organization at the University of Kentucky is dedicated to encouraging the growth of underrepresented groups within the health care field.
The Center for Business and Economic Research, the applied economic research branch of the Gatton College of Business and Economics, has released its 51st Kentucky Annual Economic Report.
Kentucky Geological Survey geologist Marty Parris is leading a two-year project to measure methane emissions from orphaned oil and gas wells in Kentucky. Methane is a potent greenhouse gas that contributes significantly to global warming.
A group of University of Kentucky researchers in the Substance Use Priority Research Area (SUPRA) is working to make studies more responsive and inclusive. The group formed a community advisory board, called the Survivors Union of the Bluegrass (SUB), including those who identify as people who use drugs and/or people in non-abstinence-based recovery.
Anastasia Curwood, associate professor of history in the College of Arts & Sciences, discusses her new book “Shirley Chisholm: Champion of Black Feminist Power Politics”
Gary Ferland, a professor in the Department of Physics and Astronomy in the College of Arts and Sciences, has been named a Fellow of the American Association for the Advancement of Science, the world’s largest general scientific society.
A University of Kentucky Markey Cancer Center program is training the next generation of cancer researchers and healthcare providers to take on the region’s cancer burden.
The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab.
